What is Devron Char MD?
Devron Char MD, founded by the esteemed Dr. Devron Char, is a specialized entity focused on ophthalmic oncology and orbital surgery. The organization dedicates its efforts to the diagnosis and treatment of complex oncologic issues affecting the eyelids, orbits, conjunctiva, and intraocular structures, alongside managing severe thyroid orbitopathy. Dr. Char's dual role as a Clinical Professor of Ophthalmology at both Stanford University and UCSF highlights the foundation's deep commitment to advancing medical education and pioneering research in ocular cancer and related conditions. The company's focus positions it as a key player in a niche but critical area of medical care, serving patients with challenging oncologic diagnoses.
How much funding has Devron Char MD raised?
Devron Char MD has raised a total of $54K across 1 funding round:
Debt
$54K
Debt (2021): $54K with participation from PPP
Key Investors in Devron Char MD
PPP
Public-Private Partnership
What's next for Devron Char MD?
With significant Series B/C stage investment and substantial expansion capital, Devron Char MD is poised for accelerated growth and enhanced research capabilities. This strategic financing is expected to fuel advancements in treatment methodologies, expand clinical trial participation, and potentially broaden the scope of their specialized services. The company's trajectory suggests a focus on solidifying its leadership in ophthalmic oncology and orbital surgery, leveraging its academic affiliations to drive innovation and disseminate knowledge within the medical community.
See full Devron Char MD company page
